Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Metabolic Syndrome in People Living With HIV Without ExperienCe to ART Who Start DoLutegravir Based-Regimen Compared With BictegrAvir Based-RegimeN After 48 Weeks (MICTLAN Trial)

NCT06629480 is registered in ClinicalTrials.gov with Instituto Mexicano del Seguro Social as lead sponsor.

NCT NCT06629480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06629480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Metabolic Syndrome in People Living With HIV Without ExperienCe to ART Who Start DoLutegravir Based-Regimen Compared With BictegrAvir Based-RegimeN After 48 Weeks (MICTLAN Trial)
Lead sponsor
Instituto Mexicano del Seguro Social
Phase
Not applicable
Overall status
Completed
Start date
June 25, 2021
Completion date
February 28, 2024
Enrollment
378 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiretroviral treatment, hiv infection, metabolic cardiovascular syndrome